Mark McClung
Geen lopende functies
Vermogen: 56 033 $ op 30-04-2024
Loopbaan van Mark McClung
Eerdere bekende functies van Mark McClung
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Operationeel Directeur | 01-11-2021 | 02-01-2024 |
| Corporate Officer/Principal | 17-04-2020 | 01-11-2021 | |
| AMGEN INC. | Corporate Officer/Principal | 01-01-2015 | 01-01-2019 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | - | - |
Opleiding van Mark McClung
| University of Guelph | Undergraduate Degree |
| York University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Canada | 3 |
Operationeel
| Undergraduate Degree | 3 |
| Corporate Officer/Principal | 3 |
| Chief Operating Officer | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
- Beurs
- Insiders
- Mark McClung
- Ervaring
